Clinical Trials
6 trialsNCT07614048 2026-05-29
Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS
Providence Health & Services
Temporarily not available
NCT04830202 2026-05-13
Expanded Access to Telisotuzumab Vedotin
AbbVie
Temporarily not available
NCT07346105 2026-01-16
Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies
Orca Biosystems, Inc.
Temporarily not available
NCT07319910 2026-01-06
PANOVA-3CA
NovoCure Ltd.
Temporarily not available
NCT05389514 2025-11-20
Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors
Providence Health & Services
Temporarily not available
NCT03842865 2025-06-05
Expanded Access of Vigil in Solid Tumors
Gradalis, Inc.
Temporarily not available